Wall Street rarely pays for the same drug twice. Once a big trial succeeds, the stock jumps and investors start...
Merck
Moderna and Merck said Wednesday their personalized mRNA cancer vaccine met its main goals in a Phase 3 trial targeting...
Fox News senior medical analyst Dr. Marc Siegel has the latest on the discounted products under President Donald Trump's plan...